Clinical Trial Update: Autoimmunity After Checkpoint Blockade

View source ↗

Summary

A clinical trial from the Abramson Cancer Center at Penn Medicine is investigating autoimmune effects after checkpoint inhibitor therapy in cancer patients; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Autoimmunity, Cancer | Status: RECRUITING